PRP & Exosomes

Exosome Facials Have No FDA Approval and Only Early Studies Behind Them

No exosome product is FDA-approved, and the human studies so far are early and limited.

No exosome product used in an exosome facial has approval from the Food and Drug Administration (FDA). An exosome facial is a cosmetic add-on that applies exosomes to the skin, often alongside microneedling. No source reviewed for this page publishes a standard price for an exosome facial.

Clinics market exosome serums and injections for skin rejuvenation and anti-aging. A polished spa setting does not change the regulatory status of the product being applied.

Is an Exosome Facial Worth It?

An exosome facial is an unproven cosmetic expense paid out of pocket. No exosome product is FDA-approved. The 2026 dermatology scoping review reports early improvement signals in wrinkles, pigmentation and scars. It lists small samples, short follow-up and non-randomized, single-arm designs among its limits. A second 2026 review says heterogeneity and nonstandardized protocols limit how far its findings apply, and that its results support further investigation.

No head-to-head trial of microneedling with exosomes against microneedling alone appears in the sources reviewed for this page. That gap means the sources give no measure of what the exosome step adds to the needling itself. Price is unstandardized as well: no source reviewed publishes a per-session figure for an exosome facial.

Anyone who wants a skin treatment with an established result will not find an exosome product that meets that bar.

What an Exosome Facial Is

Exosomes are tiny particles that cells release to signal one another. They are not living cells, unlike stem cells. The site’s guide to exosomes vs stem cells covers that difference in detail.

An exosome facial delivers these particles to the face in one of three ways:

  • Applied to the skin as a topical serum
  • Used with microneedling
  • Injected into the skin

The published studies use a wider set of routes. The 2026 dermatology scoping review covered below lists topical application, microneedling, fractional CO2 laser and injection. Clinics often pair exosomes with microneedling or a “vampire facial”-style treatment, as the site’s exosome therapy guide describes.

The source of the exosomes varies. Most exosomes in the 17 studies of the 2026 dermatology scoping review were derived from mesenchymal stem cells. A clinic’s marketed benefits are its own claims. None of them is an FDA approval. The site’s overview of regenerative medicine for skin and aesthetics places exosomes alongside the other options sold for the face.

What the Research Shows

Two 2026 reviews summarize published research on exosome therapy for skin. Both report improvements in the studies they covered. Both also name limits, so neither establishes exosome facials as an effective treatment.

The Journal of Drugs in Dermatology Scoping Review

Wang, Bajwa and Rivers published “Exosome-Based Therapies in Dermatology: A Scoping Review” in the Journal of Drugs in Dermatology in April 2026 (Volume 25, Issue 4). It covered 17 human studies published from 2020 to 2025. The designs were cohort studies, comparative trials and case series.

The conditions studied included skin rejuvenation, psoriasis, acne scars and atopic dermatitis. About 76% of the studies reported improvements in wrinkles, pigmentation, elasticity, hydration or scars.

The authors conclude that exosome therapies “demonstrate promise” for skin rejuvenation and inflammatory skin conditions. They also list the limits:

  • Small sample sizes
  • Short follow-up
  • Non-randomized, single-arm designs
  • Potential conflicts of interest

The Aesthetic Surgery Journal Review

Stack and colleagues published “Clinical Advances in Exosome-Based Therapies for Aesthetic Medicine”, a systematic review and meta-analysis, in a 2026 supplement of the Aesthetic Surgery Journal. It covered 39 human studies, 26 on skin and 13 on hair. The authors note that differences between studies and nonstandardized protocols limit how far the findings apply. They write that the results support further investigation.

What the Studies Do Not Show

The studies in the Journal of Drugs in Dermatology review had short follow-up, and neither review, as reported here, measures how long results last. No claim about the duration of exosome facial results can be supported from these sources. A safe treatment frequency is not established either.

Safety and the FDA’s Position

The FDA states in its consumer alert on regenerative medicine products: “There are currently no FDA-approved exosome products.” It adds that, as a general matter, exosome products intended to treat diseases or conditions in humans require FDA approval.

The consumer alert focuses on products intended to treat diseases or conditions. It does not discuss cosmetic or skin use of exosomes specifically. No exosome product has any FDA approval, though, so any exosome facial uses an unapproved product. The site’s FDA approval status guide covers how that status applies across regenerative treatments.

On December 6, 2019, the FDA published a public safety notification on exosome products. It followed multiple reports of serious adverse events in Nebraska patients who received unapproved products marketed as containing exosomes. The FDA worked with Nebraska state health officials on the reports. The notification says exosomes used to treat diseases in humans are generally regulated as drugs and biological products subject to premarket review and approval. It says clinics offering these products outside the FDA’s review process are “taking advantage of patients”.

The research record on side effects is thin. The 2026 Journal of Drugs in Dermatology review found adverse events were uncommon, but the events it reported after injection included granulomas, necrosis and allergic reactions. Its authors state that safety “remain[s] undefined, despite commercial availability.”

The FDA asks anyone harmed by a regenerative product to report it through its MedWatch adverse event reporting program.

What an Exosome Facial Costs

No standardized per-session price for an exosome facial is published in any source reviewed for this page. Prices vary by clinic and by what is combined with the exosomes. The sources reviewed do not support a dollar range for facials.

The closest published figure covers exosome therapy generally. The site’s exosome therapy guide reports $1,000 to $5,000 or more per treatment, paid out of pocket. That range covers all exosome treatments and is not a facial price.

Insurance does not cover cosmetic exosome treatments. The site’s insurance coverage guide explains coverage in more detail. Before booking, ask the clinic for one written total that covers every part of the visit, including any microneedling, laser or other treatment combined with the exosomes.

Microneedling With and Without Exosomes

No head-to-head randomized trial of microneedling with exosomes against microneedling alone appears in the sources reviewed. The table sets out what the sources establish for an exosome facial and what they leave open.

QuestionWhat the sources show
Is any exosome product FDA-approved?No. The FDA states there are no FDA-approved exosome products.
How many human studies exist, and of what design?One 2026 review covered 17 human studies and another covered 39. The first cites small samples, short follow-up and non-randomized, single-arm designs.
How long do results last?Not established. Studies in the 2026 Journal of Drugs in Dermatology review had short follow-up.
How often is it safe to repeat?Not established. No FDA-reviewed schedule exists.
Does adding exosomes improve microneedling?Not established. No head-to-head trial appears in the sources reviewed.
What does it cost?No standardized price is published for an exosome facial.

The site’s PRP vs exosome comparison covers platelet-rich plasma (PRP).

Questions to Ask Before Booking

The FDA’s public safety notification on exosome products advises patients to ask whether the FDA has reviewed a treatment, and to request the investigational new drug application (IND) number and the FDA’s acknowledgment. Six questions cover that advice and the cost gaps above:

  1. What exact exosome product is used, and which company makes it?
  2. Is the product FDA-approved, or is it being used under an IND? Ask for the IND number and the FDA acknowledgment.
  3. What is applied to the face, and how: topical serum, microneedling or injection?
  4. Who performs the treatment, and what license does that person hold?
  5. What is the written policy for adverse events and refunds?
  6. What is the price of the full protocol, with every session and add-on listed?

The notification also tells patients to understand the consent form and known risks before signing, and to confirm the IND details with their own health care provider. For treatment abroad, the FDA does not oversee treatments given in other countries.

Who Should Skip It and What Would Change This Answer

People expecting a proven result should skip an exosome facial, because the published evidence does not establish one. People with a weakened immune system or an active infection should ask their own clinician before any exosome treatment. The FDA has published no contraindication list for exosome products.

Two developments would change this verdict:

  • Randomized controlled trials with larger samples and longer follow-up
  • An FDA approval of a specific exosome product

Bottom Line for Buyers

For adults weighing an exosome facial, the treatment remains an unproven cosmetic add-on paid out of pocket. One 2026 review lists small samples and short follow-up among its limits, the other cites heterogeneity and nonstandardized protocols, and the FDA lists no approved exosome product. Anyone who books anyway should choose a licensed, dermatologist-led practice that names its product and the source of the exosomes. The same practice should put its adverse-event and refund policy in writing before the first session.

Before paying for an exosome facial, work through the red-flags checklist for vetting a clinic with the provider’s written answers in hand.

Frequently asked questions

How long do exosome facial results last?

No source reviewed for this page establishes how long exosome facial results last. The FDA has not reviewed any timeline, and no exosome product is FDA-approved. A 2026 scoping review in the Journal of Drugs in Dermatology lists short follow-up as a limit of the studies it covered. A timeline quoted by a clinic is marketing.

How often can you get an exosome facial?

No FDA-reviewed schedule exists for exosome facials, and no source reviewed for this page establishes a safe treatment frequency.

Are exosome facial before and after photos reliable?

Before and after photos are not controlled evidence. The 2026 Journal of Drugs in Dermatology review lists non-randomized, single-arm designs and potential conflicts of interest among the limits of the studies it covered.

Which is better, microneedling or exosomes?

The sources reviewed for this page do not establish which is better. No head-to-head trial of microneedling with exosomes against microneedling alone appears in them, and no exosome product is FDA-approved.

Are exosomes a gimmick?

The evidence on exosomes for skin is early and limited, and no exosome product has FDA approval. The 2026 Journal of Drugs in Dermatology review reports improvement signals in small human studies. The 2026 Aesthetic Surgery Journal review's authors say heterogeneity and nonstandardized protocols limit how far its findings apply. That record does not establish exosome facials as a proven therapy.

What is the dark side of exosomes, and what are the side effects?

The main concerns are an unapproved product and a safety record the researchers themselves call undefined. The 2026 Journal of Drugs in Dermatology review found adverse events were uncommon, but it reported granulomas, necrosis and allergic reactions after injection. In 2019 the FDA published a public safety notification on exosome products after serious adverse events in Nebraska patients who received unapproved products marketed as containing exosomes.

Is an exosome facial painful, and how many sessions are needed?

Neither pain levels nor the number of sessions is established in the sources reviewed for this page. The FDA has no schedule for exosome treatments, and no exosome product is approved. Ask the provider in writing how many sessions the protocol includes and what each one costs.

Can exosome facials cause cancer?

No source reviewed for this page establishes a link between exosome facials and cancer, and none rules one out. The 2026 Journal of Drugs in Dermatology review states that safety remains undefined. The site's exosome therapy guide covers the broader safety record.

Do exosome face creams work?

No exosome face cream or serum is FDA-approved, and the evidence for topical use is early. The 2026 Journal of Drugs in Dermatology review included topical application among the delivery methods in its 17 human studies. Its authors cite small samples, short follow-up and non-randomized, single-arm designs as limits.

How do I find an exosome facial provider near me and vet them?

Start with the provider's answers rather than its location. Ask what product it uses, who makes it, whether it has FDA approval or an investigational new drug application (IND), and who performs the treatment. Then run the clinic through the red-flags checklist for vetting a clinic. The FDA does not oversee treatments given in other countries.

Does insurance cover an exosome facial?

No. Insurance does not cover cosmetic exosome treatments, and the site's exosome therapy guide reports that no insurer covers exosome therapy at all. The full cost is paid out of pocket. See the insurance coverage guide for how coverage works across regenerative treatments.

Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.